Arrowhead Pharmaceuticals, Inc.
2019 Q4 - 2026 Q1 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2026 Q1 | 5/8/2026 | 1,967 | 0.0% | 31,371 | 3/31/2026 |
| 2024 Q4 | 2/11/2025 | 519 | 0.0% | 27,628 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 534 | 0.0% | 27,580 | 9/30/2024 |
| 2024 Q2 | 8/15/2024 | 720 | 0.0% | 27,720 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 790 | 0.0% | 27,635 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 730 | 0.0% | 23,847 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 639 | 0.0% | 23,773 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 847 | 0.0% | 23,757 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 610 | 0.0% | 24,029 | 3/31/2023 |
| 2022 Q4 | 2/21/2023 | 397 | 0.0% | 9,796 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 505 | 0.0% | 15,287 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 623 | 0.0% | 17,698 | 6/30/2022 |
| 2022 Q1 | 5/9/2022 | 806 | 0.0% | 17,516 | 3/31/2022 |
| 2021 Q4 | 2/3/2022 | 1,146 | 0.0% | 17,283 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 1,075 | 0.0% | 17,223 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 1,436 | 0.0% | 17,335 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 1,148 | 0.0% | 17,313 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 2,711 | 0.0% | 35,332 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 1,529 | 0.0% | 35,412 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 1,529 | 0.0% | 35,412 | 6/30/2020 |
| 2020 Q1 | 5/8/2020 | 1,001 | 0.0% | 34,785 | 3/31/2020 |
| 2019 Q4 | 2/7/2020 | 1,814 | 0.0% | 28,592 | 12/31/2019 |